ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-allergic Drugs Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-16R9189
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti allergic Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-allergic Drugs Market Research Report 2024

Code: QYRE-Auto-16R9189
Report
March 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
TEVA
GlaxoSmithKline PLC
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
Johnson and Johnson
Sanofi

Anti-allergic Drugs Market Size

The global Anti-allergic Drugs market was valued at US$ 10980 million in 2023 and is anticipated to reach US$ 14400 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.

Anti-allergic Drugs Market

Anti-allergic Drugs Market

Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs.

Report Scope

The Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-allergic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-allergic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
Market Segmentation

Scope of Anti-allergic Drugs Market Report

Report Metric Details
Report Name Anti-allergic Drugs Market
Accounted market size in 2023 US$ 10980 million
Forecasted market size in 2030 US$ 14400 million
CAGR 3.9%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Oral Drugs
  • Non-Oral Drugs
Segment by Sales Channel
  • Online
  • Offline
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sales Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-allergic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-allergic Drugs Market growing?

Ans: The Anti-allergic Drugs Market witnessing a CAGR of 3.9% during the forecast period 2024-2030.

What is the Anti-allergic Drugs Market size in 2030?

Ans: The Anti-allergic Drugs Market size in 2030 will be US$ 14400 million.

What is the market share of major companies in Anti-allergic Drugs Market?

Ans: Global top two companies hold a share over 10%.

Who are the main players in the Anti-allergic Drugs Market report?

Ans: The main players in the Anti-allergic Drugs Market are Sanofi, Johnson And Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Sun Pharma, UCB Pharma, Yangtze River Pharmaceutical Group, Hainan Poly Pharm, Chongqing Huapont Pharmaceutical, Dawnrays

What are the Type segmentation covered in the Anti-allergic Drugs Market report?

Ans: The Types covered in the Anti-allergic Drugs Market report are Oral Drugs, Non-Oral Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-allergic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drugs
1.2.3 Non-Oral Drugs
1.3 Market by Sales Channel
1.3.1 Global Anti-allergic Drugs Market Growth by Sales Channel: 2019 VS 2023 VS 2030
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-allergic Drugs Market Perspective (2019-2030)
2.2 Anti-allergic Drugs Growth Trends by Region
2.2.1 Global Anti-allergic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-allergic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-allergic Drugs Market Dynamics
2.3.1 Anti-allergic Drugs Industry Trends
2.3.2 Anti-allergic Drugs Market Drivers
2.3.3 Anti-allergic Drugs Market Challenges
2.3.4 Anti-allergic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-allergic Drugs Players by Revenue
3.1.1 Global Top Anti-allergic Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-allergic Drugs Revenue
3.4 Global Anti-allergic Drugs Market Concentration Ratio
3.4.1 Global Anti-allergic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-allergic Drugs Revenue in 2023
3.5 Anti-allergic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-allergic Drugs Product Solution and Service
3.7 Date of Enter into Anti-allergic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-allergic Drugs Breakdown Data by Type
4.1 Global Anti-allergic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-allergic Drugs Breakdown Data by Sales Channel
5.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2019-2024)
5.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030)
6 North America
6.1 North America Anti-allergic Drugs Market Size (2019-2030)
6.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-allergic Drugs Market Size by Country (2019-2024)
6.4 North America Anti-allergic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-allergic Drugs Market Size (2019-2030)
7.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-allergic Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-allergic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-allergic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-allergic Drugs Market Size (2019-2030)
9.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-allergic Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-allergic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-allergic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anti-allergic Drugs Introduction
11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Company Detail
11.2.2 Johnson And Johnson Business Overview
11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction
11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024)
11.2.5 Johnson And Johnson Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Anti-allergic Drugs Introduction
11.3.4 Merck Revenue in Anti-allergic Drugs Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Anti-allergic Drugs Introduction
11.4.4 Teva Revenue in Anti-allergic Drugs Business (2019-2024)
11.4.5 Teva Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Anti-allergic Drugs Introduction
11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Anti-allergic Drugs Introduction
11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 UCB Pharma
11.8.1 UCB Pharma Company Detail
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Anti-allergic Drugs Introduction
11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.8.5 UCB Pharma Recent Development
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Company Detail
11.9.2 Yangtze River Pharmaceutical Group Business Overview
11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction
11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024)
11.9.5 Yangtze River Pharmaceutical Group Recent Development
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Company Detail
11.10.2 Hainan Poly Pharm Business Overview
11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction
11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024)
11.10.5 Hainan Poly Pharm Recent Development
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Company Detail
11.11.2 Chongqing Huapont Pharmaceutical Business Overview
11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction
11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024)
11.11.5 Chongqing Huapont Pharmaceutical Recent Development
11.12 Dawnrays
11.12.1 Dawnrays Company Detail
11.12.2 Dawnrays Business Overview
11.12.3 Dawnrays Anti-allergic Drugs Introduction
11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024)
11.12.5 Dawnrays Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Merck
TEVA
GlaxoSmithKline PLC
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
Johnson and Johnson
Sanofi
List of Tables
    Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral Drugs
    Table 3. Key Players of Non-Oral Drugs
    Table 4. Global Anti-allergic Drugs Market Size Growth by Sales Channel (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Anti-allergic Drugs Market Share by Region (2019-2024)
    Table 8. Global Anti-allergic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Anti-allergic Drugs Market Share by Region (2025-2030)
    Table 10. Anti-allergic Drugs Market Trends
    Table 11. Anti-allergic Drugs Market Drivers
    Table 12. Anti-allergic Drugs Market Challenges
    Table 13. Anti-allergic Drugs Market Restraints
    Table 14. Global Anti-allergic Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Anti-allergic Drugs Market Share by Players (2019-2024)
    Table 16. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
    Table 17. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Anti-allergic Drugs Product Solution and Service
    Table 21. Date of Enter into Anti-allergic Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Anti-allergic Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Anti-allergic Drugs Revenue Market Share by Type (2019-2024)
    Table 25. Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2025-2030)
    Table 27. Global Anti-allergic Drugs Market Size by Sales Channel (2019-2024) & (US$ Million)
    Table 28. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019-2024)
    Table 29. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030) & (US$ Million)
    Table 30. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2025-2030)
    Table 31. North America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Anti-allergic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Sanofi Company Detail
    Table 47. Sanofi Business Overview
    Table 48. Sanofi Anti-allergic Drugs Product
    Table 49. Sanofi Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 50. Sanofi Recent Development
    Table 51. Johnson And Johnson Company Detail
    Table 52. Johnson And Johnson Business Overview
    Table 53. Johnson And Johnson Anti-allergic Drugs Product
    Table 54. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 55. Johnson And Johnson Recent Development
    Table 56. Merck Company Detail
    Table 57. Merck Business Overview
    Table 58. Merck Anti-allergic Drugs Product
    Table 59. Merck Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 60. Merck Recent Development
    Table 61. Teva Company Detail
    Table 62. Teva Business Overview
    Table 63. Teva Anti-allergic Drugs Product
    Table 64. Teva Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 65. Teva Recent Development
    Table 66. GlaxoSmithKline Company Detail
    Table 67. GlaxoSmithKline Business Overview
    Table 68. GlaxoSmithKline Anti-allergic Drugs Product
    Table 69. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 70. GlaxoSmithKline Recent Development
    Table 71. Bayer Company Detail
    Table 72. Bayer Business Overview
    Table 73. Bayer Anti-allergic Drugs Product
    Table 74. Bayer Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 75. Bayer Recent Development
    Table 76. Sun Pharma Company Detail
    Table 77. Sun Pharma Business Overview
    Table 78. Sun Pharma Anti-allergic Drugs Product
    Table 79. Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 80. Sun Pharma Recent Development
    Table 81. UCB Pharma Company Detail
    Table 82. UCB Pharma Business Overview
    Table 83. UCB Pharma Anti-allergic Drugs Product
    Table 84. UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 85. UCB Pharma Recent Development
    Table 86. Yangtze River Pharmaceutical Group Company Detail
    Table 87. Yangtze River Pharmaceutical Group Business Overview
    Table 88. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
    Table 89. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 90. Yangtze River Pharmaceutical Group Recent Development
    Table 91. Hainan Poly Pharm Company Detail
    Table 92. Hainan Poly Pharm Business Overview
    Table 93. Hainan Poly Pharm Anti-allergic Drugs Product
    Table 94. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 95. Hainan Poly Pharm Recent Development
    Table 96. Chongqing Huapont Pharmaceutical Company Detail
    Table 97. Chongqing Huapont Pharmaceutical Business Overview
    Table 98. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product
    Table 99. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 100. Chongqing Huapont Pharmaceutical Recent Development
    Table 101. Dawnrays Company Detail
    Table 102. Dawnrays Business Overview
    Table 103. Dawnrays Anti-allergic Drugs Product
    Table 104. Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
    Table 105. Dawnrays Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Anti-allergic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Anti-allergic Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Oral Drugs Features
    Figure 4. Non-Oral Drugs Features
    Figure 5. Global Anti-allergic Drugs Market Size Comparison by Sales Channel (2024-2030) & (US$ Million)
    Figure 6. Global Anti-allergic Drugs Market Share by Sales Channel: 2023 VS 2030
    Figure 7. Online Case Studies
    Figure 8. Offline Case Studies
    Figure 9. Anti-allergic Drugs Report Years Considered
    Figure 10. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Anti-allergic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Anti-allergic Drugs Market Share by Region: 2023 VS 2030
    Figure 13. Global Anti-allergic Drugs Market Share by Players in 2023
    Figure 14. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2023
    Figure 16. North America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Anti-allergic Drugs Market Share by Country (2019-2030)
    Figure 18. United States Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. Canada Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Europe Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Anti-allergic Drugs Market Share by Country (2019-2030)
    Figure 22. Germany Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. France Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. U.K. Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Italy Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Russia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Anti-allergic Drugs Market Share by Region (2019-2030)
    Figure 30. China Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Japan Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. South Korea Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. India Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Australia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Latin America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Anti-allergic Drugs Market Share by Country (2019-2030)
    Figure 38. Mexico Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Brazil Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Anti-allergic Drugs Market Share by Country (2019-2030)
    Figure 42. Turkey Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 45. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 46. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 47. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 49. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 50. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 51. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 52. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 53. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 54. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 55. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions